Mark Veerman

508 total citations
10 papers, 368 citations indexed

About

Mark Veerman is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Nutrition and Dietetics. According to data from OpenAlex, Mark Veerman has authored 10 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Nutrition and Dietetics. Recurrent topics in Mark Veerman's work include Clinical Nutrition and Gastroenterology (2 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Central Venous Catheters and Hemodialysis (2 papers). Mark Veerman is often cited by papers focused on Clinical Nutrition and Gastroenterology (2 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Central Venous Catheters and Hemodialysis (2 papers). Mark Veerman collaborates with scholars based in United States, Belgium and United Kingdom. Mark Veerman's co-authors include William H. Meetze, Josef Neu, Nancy Auestad, Robert D. Christensen, Robin K. Ohls, T Knight, Michael J. Dallas, John W. Sleasman, Carolyn Carter and Darlene A Calhoun and has published in prestigious journals such as PEDIATRICS, Journal of Nutrition and The Journal of Pediatrics.

In The Last Decade

Mark Veerman

10 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Veerman United States	7	223	120	67	61	46	10	368
G Di Bitonto Italy	9	64 0.3×	75 0.6×	46 0.7×	52 0.9×	71 1.5×	14	363
David K. Melhorn United States	10	166 0.7×	97 0.8×	55 0.8×	149 2.4×	127 2.8×	12	464
G Riedler Switzerland	6	88 0.4×	59 0.5×	22 0.3×	23 0.4×	52 1.1×	12	298
Aldo Claris Appiani Italy	10	114 0.5×	179 1.5×	35 0.5×	56 0.9×	28 0.6×	17	496
M R Narkewicz United States	9	55 0.2×	89 0.7×	41 0.6×	41 0.7×	9 0.2×	24	385
Henning Lenhartz Germany	8	105 0.5×	17 0.1×	36 0.5×	48 0.8×	22 0.5×	18	345
David J. Card United Kingdom	10	212 1.0×	34 0.3×	17 0.3×	17 0.3×	16 0.3×	15	349
Valeria Fazio Italy	14	54 0.2×	37 0.3×	41 0.6×	31 0.5×	50 1.1×	27	423
Lawrence Bennett United States	5	83 0.4×	41 0.3×	34 0.5×	51 0.8×	4 0.1×	6	328
Cesar Rudzki United States	7	92 0.4×	42 0.3×	64 1.0×	36 0.6×	22 0.5×	10	309

Countries citing papers authored by Mark Veerman

Since Specialization

Citations

This map shows the geographic impact of Mark Veerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Veerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Veerman more than expected).

Fields of papers citing papers by Mark Veerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Veerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Veerman. The network helps show where Mark Veerman may publish in the future.

Co-authorship network of co-authors of Mark Veerman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Veerman. A scholar is included among the top collaborators of Mark Veerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Veerman. Mark Veerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Patel, Aarti A., et al.. (2014). The Economic Burden to Medicare of Stroke Events in Atrial Fibrillation Populations With and Without Thromboprophylaxis. Population Health Management. 17(3). 159–165. 10 indexed citations

Calhoun, Darlene A, et al.. (2000). Stability of Filgrastim and Epoetin Alfa in a System Designed for Enteral Administration in Neonates. Annals of Pharmacotherapy. 34(11). 1257–1261. 19 indexed citations

Calhoun, Darlene A, et al.. (2000). Granulocyte Colony-Stimulating Factor Serum and Urine Concentrations in Neutropenic Neonates Before and After Intravenous Administration of Recombinant Granulocyte Colony-Stimulating Factor. PEDIATRICS. 105(2). 392–397. 21 indexed citations

Calhoun, Darlene A, et al.. (2000). Stability of Filgrastim and Epoetin Alfa in a System Designed for Enteral Administration in Neonates. Annals of Pharmacotherapy. 34. 1257–1261. 1 indexed citations

Neu, Josef, William H. Meetze, Mark Veerman, et al.. (1997). Enteral glutamine supplementation for very low birth weight infants decreases morbidity. The Journal of Pediatrics. 131(5). 691–699. 188 indexed citations

Ohls, Robin K., Mark Veerman, & Robert D. Christensen. (1996). Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution. The Journal of Pediatrics. 128(4). 518–523. 64 indexed citations

Meetze, William H., et al.. (1996). Enteral Glutamine Supplementation for the Very Low Birthweight Infant: Plasma Amino Acid Concentrations. Journal of Nutrition. 126(4 Suppl). 1115S–1120S. 40 indexed citations

Veerman, Mark, et al.. (1991). Use Of Activated Charcoal To Reduce Elevated Serum Phenobarbital Concentration In A Neonate. Journal of Toxicology Clinical Toxicology. 29(1). 53–58. 6 indexed citations

Veerman, Mark. (1990). Excipients in Valproic Acid Syrup May Cause Diarrhea: A Case Report. DICP. 24(9). 832–833. 5 indexed citations

10.

Veerman, Mark, Richard D. Leff, & Robert J. Roberts. (1985). Influence of two piston-type infusion pumps on hemolysis of infused red blood cells. American Journal of Health-System Pharmacy. 42(3). 626–628. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact